Your participation in the study will last for 22 weeks, or about 5 months. You will only be taking the study medication for 12 of these weeks. You will have about 30 study visits at our study site, including a screening visit to see if you qualify. You must be able to attend these visits in order to participate.
Your safety will be closely monitored throughout the study by a study nurse and physician. One important part of this monitoring involves regular blood draws during your visits to our center. You must be comfortable with needles and willing to provide blood samples throughout this study. We will also monitor your drug use during the study to determine whether this is affected by your treatment.